2023-11-24 11:28:52
La Fundación PharmaMar yesterday celebrated the 1st edition of the Argonauta Fundación PharmaMar Awards, recognizing people or projects that have contributed significantly in recent years to the advancement of medicine, science and health in our society.
It was a night when The power of science and the need to contribute to its dissemination and promotion from different areas was revealed., to advance the improvement of people’s quality of life. In addition, it brought together the most relevant personalities of recent years at a scientific and medical level, both national and international.
Such and as José María Fernández Sousa-Faro, president of the PharmaMar Foundation and PharmaMar, highlighted: “We are very proud to be able to bring together such distinguished personalities, whose work has contributed significantly to people’s health, in the first edition of our awards. From the PharmaMar Foundation, with these awards, we want to encourage you to continue working to achieve notable advances in scientific research and health care.”
The award for the best clinical case has been awarded to Louis Gros, medical oncologist and Postdoc fellow, Early Lung and Cardiac Action Program (ELCAP) Icahn School of Medicine at Mount Sinai, New York (USA), for his innovative work in the treatment of Advanced and refractory peritoneal mesothelioma, performed in collaboration with Dr. Antonia Digklia. A work that not only represents a significant advance in the field of oncology, but also It also reflects a deep dedication to the well-being and hope of patients.
In the category, the award for the best care provision for a hospitalized COVID patient was awarded to Pedro Landete, Pulmonologist at La Princesa University Hospital, for his contribution during one of the most challenging periods in modern medical history, where his experience and knowledge helped improve the quality of care and the life of many patients with COVID-19.
The award for lifetime achievement in basic research was awarded to Adolfo García-Sastre, director of the Global Health and Emerging Pathogens Institute at the Icahn School of Medicine at Mount Sinaí, New York (USA), for his exceptional career in the field of virology. and immunology, standing out for its innovations in the development of vaccines and its crucial contribution to the understanding and combating of viral pathogens such as influenza, SARS-CoV-2 and other viruses of importance to human health.
Finally, the award for career in clinical research was presented to Josep Tabernero, Head of the Medical Oncology Service at the Vall d’Hebron Hospital in Barcelona, Director of the Vall d’Hebron Institute of Oncology (VHIO), for his distinguished career and recognized leadership in the development of molecular therapies once morest cancer, as well as its significant contribution to translational medicinereflected in his extensive scientific work and his global impact on the oncology community.
To decide the winners, the jury was chaired by figures such as Vicente Estrada, head of Infectious Diseases at the San Carlos Clinical Hospital; Pablo Guisado, specialist in Internal Medicine Quirónsalud Madrid University Hospital, Isabel Sola, scientist at the Higher Council for Scientific Research (CSIC); or Ana Oaknin, head of the Gynecological Cancer Program at the Vall d’Hebron Oncology Institute.
First year of activity PharmaMar Foundation
The PharmaMar Foundation, which began its activity at the beginning of this year 2023, has among its main objectives to disseminate, promote and support scientific research in the field of health, focusing especially on oncology and infectious diseases. Along these lines, during the first year of activity, the Foundation has launched various initiatives in four key areas: scientific dissemination, promotion of research, training and defense of marine biodiversity.
Among the most relevant are the sponsorship of the International Symposium on Natural Products of Marine Origin (MaNaPro), the main scientific event worldwide on natural products of marine origin; the launch of a Cycle of Scientific Conferences for all audiences, together with the Student Residence and the National Archaeological Museum; support for the Postgraduate Degree in Sarcoma of the Spanish Society of Hospital Pharmacy at the University of Alcalá de Henares; or the promotion of several training days for journalists, titled “Science up to date”, in different health areas for journalists, together with ANIS (National Association of Health Informants).
Family photo caption: (from left to right) José Antonio Ramos-Vilariño, Oncology Medical Manager at PharmaMar; Loius Gros, medical oncologist and Postdoc fellow, Early Lung and Cardiac Action Program (ELCAP) at the Icahn School of Medicine at Mount Sinai, New York (USA); Pedro Landete, Pulmonologist at La Princesa University Hospital; Diego López, director of the Virology area at PharmaMar, José María Fernández Sousa-Faro, president of the PharmaMar Foundation and PharmaMar; Adolfo García-Sastre, director of the Global Health and Emerging Pathogens Institute at the Icahn School of Medicine at Mount Sinaí, New York (USA); Luis Enjuanes, CSIC Research professor and director of the coronavirus laboratory at the National Biotechnology Center; Josep Tabernero, head of the Medical Oncology Service at the Vall d’Hebron Hospital in Barcelona, Director of the Vall d’Hebron Institute of Oncology (VHIO); Emiliano Calvo, director of Clinical Research at the START Madrid Clinical Trials Unit.
1700855754
#PharmaMar #Foundation #recognizes #great #figures #science #medicine #Argonauta #Awards